Search

everythinglearnresearchcommunity

for

Search:↓

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Finasteride reduces movement issues in Parkinson's disease rats.

The interdisciplinary approach improved the quality of life for a Parkinson's patient and eased staff workload.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Increasing research diversity is key for better understanding and treating Parkinson's Disease.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

The document concludes that stem cell therapies lack solid proof of effectiveness, except for blood system treatments, and criticizes the ethical issues and commercial exploitation in the field.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Eclipta Alba may help reverse memory loss caused by scopolamine, suggesting it could treat Alzheimer's-related memory issues.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Taking triterpenoids from Ganoderma lucidum over a long time can help slow down brain aging and improve overall health in mice.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Some traditional Chinese medicines may have anti-aging benefits and could help with hair growth, but more research is needed.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Piezoelectric Nanogenerators are promising for non-invasive health monitoring but need efficiency and durability improvements.